June 23rd 2025
In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Infused Chemotherapy Use in the Elderly After Patent Expiration
As calls for improving the quality and cost efficiency of oncology increase, future empirical work is needed to examine the responsiveness of oncologists' treatment decision making to incentives among patients of all ages and insurance types.
Read More
Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.
Read More
Impact of Payment Reform on Chemotherapy at the End of Life
Payment reform may be used to better align appropriate financial incentives with better quality of care.
Read More
Optimal Approach to Improving Trauma Triage Decisions: A Cost-Effectiveness Analysis
To set priorities for quality improvement in trauma triage, we compared the cost-effectiveness of current practice with interventions to improve physician adherence to clinical guidelines.
Read More
A Dementia Care Management Intervention: Which Components Improve Quality?
Specifically trained care managers are essential for quality gains from a dementia care management program; even higher quality accrues with coordination across community and primary care.
Read More